Vikas Lifecare Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Vikas Lifecare şirketinin toplam hissedar öz sermayesi ₹5.4B ve toplam borcu ₹614.6M olup, bu da borç-öz sermaye oranını 11.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₹7.3B ve ₹1.8B dir.

Anahtar bilgiler

11.3%

Borç/özkaynak oranı

₹614.59m

Borç

Faiz karşılama oranı	n/a
Nakit	₹20.80m
Eşitlik	₹5.45b
Toplam yükümlülükler	₹1.82b
Toplam varlıklar	₹7.27b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 542655 'nin kısa vadeli varlıkları ( ₹1.5B ) kısa vadeli yükümlülüklerini ( ₹1.3B ) aşıyor.

Uzun Vadeli Yükümlülükler: 542655 şirketinin kısa vadeli varlıkları ( ₹1.5B ) uzun vadeli yükümlülüklerini ( ₹529.9M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 542655 'nin net borç/öz sermaye oranı ( 10.9% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 542655 'nin borç/öz sermaye oranı son 5 yılda 55.3% seviyesinden 11.3% seviyesine düştü.

Borç Kapsamı: 542655 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.

Faiz Kapsamı: 542655 şirketinin borçlarına ilişkin faiz ödemelerinin EBIT tarafından iyi bir şekilde karşılanıp karşılanmadığını belirlemek için yeterli veri yok.

Vikas Lifecare Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Second quarter 2025 earnings released: EPS: ₹0.03 (vs ₹0.06 in 2Q 2024)

Vikas Lifecare Limited to Report Q2, 2025 Results on Oct 22, 2024

New minor risk - Market cap size

Vikas Lifecare Limited, Annual General Meeting, Sep 29, 2024

First quarter 2025 earnings released

Vikas Lifecare Limited to Report Q1, 2025 Results on Jul 20, 2024

A Consortium including Vikas Lifecare Limited (NSEI:VIKASLIFE) made a bid to acquire Ebix, Inc. (OTCPK:EBIX.Q).

Full year 2024 earnings released: EPS: ₹0.09 (vs ₹0.12 loss in FY 2023)

Vikas Lifecare Limited Approves Executive Changes

Vikas Lifecare Limited to Report Q4, 2024 Results on May 29, 2024

Vikas Lifecare Limited Appoints Sanjay Kumar Jaiswal as Compliance Officer

Vikas Lifecare Limited announced that it has received INR 242.5 million in funding from Sylph Technologies Limited, Srestha Finvest Limited

Third quarter 2024 earnings released: ₹0.03 loss per share (vs ₹0.05 profit in 3Q 2023)

Vikas Lifecare Limited to Report Q3, 2024 Results on Feb 13, 2024

Vikas Lifecare Limited Announces CEO Changes

Less than half of directors are independent

Vikas Lifecare Limited Announces Resignation of Ruby Bansal as Non-Executive Independent Director

Second quarter 2024 earnings released: EPS: ₹0.06 (vs ₹0.018 in 2Q 2023)

Vikas Lifecare Limited to Report Q2, 2024 Results on Oct 17, 2023

New minor risk - Share price stability

Vikas Lifecare Limited (NSEI:VIKASLIFE) acquired 98% stake in MSR Apparels Private Limited for INR 125 million.

First quarter 2024 earnings released: EPS: ₹0.08 (vs ₹0.022 in 1Q 2023)

Vikas Lifecare Limited, Annual General Meeting, Sep 27, 2023

Vikas Lifecare Limited to Report Q1, 2024 Results on Aug 12, 2023

Vikas Lifecare Limited Announces Appointment of Chandan Kumar as Director (Finance) Cum Chief Financial Officer

Full year 2023 earnings released: ₹0.11 loss per share (vs ₹0.31 profit in FY 2022)

Third quarter 2023 earnings released: EPS: ₹0.05 (vs ₹0.03 in 3Q 2022)

Vikas Lifecare Limited Announces Appointment of Mr. Balwant Kumar Bhushan as an Additional Director

Vikas Lifecare Limited to Report Q3, 2023 Results on Jan 25, 2023

Investor sentiment deteriorated over the past week

High number of new and inexperienced directors

Second quarter 2023 earnings released: EPS: ₹0.018 (vs ₹0.029 in 2Q 2022)

Vikas Lifecare Limited to Report Q2, 2023 Results on Oct 21, 2022

Vikas Lifecare Limited (BSE:542655) acquired 30% stake in Ardh Sainik Canteen Limited from its existing stakeholders for INR 150 million.

Investor sentiment improved over the past week

Vikas Lifecare Limited Approves Appointment of Mr. Chandan Kumar as A Director of Company

Vikas Lifecare Limited, Annual General Meeting, Sep 29, 2022

Vikas Lifecare Limited has completed a Follow-on Equity Offering in the amount of INR 499.999997 million.

First quarter 2023 earnings released: EPS: ₹0.23 (vs ₹0.004 in 1Q 2022)

Vikas Lifecare Limited Announces Addition of 'Almonds and Walnuts' to Company's Agro-Products Division Offerings

Vikas Lifecare Limited has completed a Follow-on Equity Offering in the amount of INR 500 million.

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: ₹0.31 (vs ₹0.053 loss in FY 2021)

Vikas Lifecare Limited to Report Q4, 2022 Results on May 28, 2022

High number of new and inexperienced directors

Vikas Lifecare Limited (BSE:542655) agreed to acquire a 75% stake in Genesis Gas Solutions Private Limited for CAD 250 million.

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released

Independent Director Meena Bansal has left the company

Chief Financial Officer Chandan Bhardwaj has left the company

Independent & Non-Executive Director Pankaj Gupta has left the company

Independent & Non-Executive Director Pankaj Gupta has left the company

Non-Executive Director recently sold ₹20m worth of stock

Non-Executive Director recently sold ₹67m worth of stock

Vikas Lifecare Limited (BSE:542655) agreed to acquire Hydrolina Biotec Private Limited.

Vikas Multicorp Limited (BSE:542655) completed the acquisition of an unknown stake in Advik Laboratories Limited (BSE:531686) from Advik's promoters.

Full year 2021 earnings released: ₹0.05 loss per share (vs ₹0.021 profit in FY 2020)

Vikas Lifecare Limited has completed a Follow-on Equity Offering in the amount of INR 490.986666 million.

Company Secretary has left the company

New 90-day low: ₹3.27

Insider recently sold ₹31m worth of stock

New 90-day low: ₹4.96

Vikas Multicorp Limited (BSE:542655) agreed to acquire an unknown stake in Advik Laboratories Limited (BSE:531686) from Advik's promoters.

Vikas Multicorp Limited to Report Q3, 2021 Results on Jan 12, 2021

New 90-day low: ₹6.61

Insider recently sold ₹25m worth of stock

Insider recently sold ₹54m worth of stock

Insider recently sold ₹44m worth of stock

First half earnings released

New 90-day low: ₹6.75

Vikas Multicorp Limited to Report Q2, 2021 Results on Oct 23, 2020

Insider recently sold ₹28m worth of stock

Vikas Multicorp Limited to Report Q1, 2021 Results on Aug 01, 2020

New 90-day high - ₹15.91

Finansal Durum Analizi